[PDF] Top 20 Pulmonary function in patients with Huntington’s Disease
Has 10000 "Pulmonary function in patients with Huntington’s Disease" found on our website. Below are the top 20 most common "Pulmonary function in patients with Huntington’s Disease".
Pulmonary function in patients with Huntington’s Disease
... For MEP assessment, participants were asked to breathe in to total lung capacity and then to blow hard into the mouthpiece. For MIP assessment, participants were instructed to breath out to residual volume and then to ... See full document
8
Effect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial
... COPD patients who satisfied the criteria of the Global initiative for chronic Obstructive Lung Disease (GOLD) guide- lines, stages ...The patients in the Waon group received both repeated Waon ... See full document
7
Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction
... CPFE patients were compared with 49 stable COPD patients who met our imaging ...These patients were seen at the outpatient clinic of Shinshu University Hospital between October 2009 and October 2012 ... See full document
7
Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data
... Huntington’s disease (HD) is a rare, genetic, neurode- generative and ultimately fatal disease with no cure or progression-delaying treatment currently ...HD patients present with a triad of ... See full document
8
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
... Huntington’s disease (HD) and is the first deuterated medication that has been US Food and Drug Adminis- tration (FDA)-approved for therapeutic ...both patients and ... See full document
7
A review of pulmonary function in Parkinson’s disease
... Nineteen patients in the PD group and 5 controls were smokers, with all smokers being ...of pulmonary dysfunction in the PD group was restrictive; however, they did not publish exact numbers and they noted ... See full document
11
Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge
... though patients from all severity strata were included, the state of their underlying lung disease had to be relatively ...999 patients with coronary disease or risk factors were randomized to ... See full document
9
PKR involvement in Alzheimer’s disease
... AD patients dis- played marked immunohistochemical positivity for phosphorylated PKR and eIF2α [45] ...Parkinson’s disease (PD) and Huntington’s disease (HD) patients, and they found increased ... See full document
10
Management of Huntington’s disease: role of tetrabenazine
... Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder characterized by progressive involuntary movements, neuropsychiatric disturbances, and cognitive ...HD patients and to report ... See full document
7
Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
... of Disease, Frontiers in Cellular Neuroscience, and Cell Death and Disease; is a consultant for the Neurological Institute; and has received research support from Dorpmans-Wigmans ...ADCA Patients’ ... See full document
13
Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients
... Pulmonary function was determined on the same day as CT images were acquired, using a flow-sensing spirometer (FUDAC-77; Fukuda Denshi Co, Ltd, Tokyo, ... See full document
10
Novel targets for Huntington’s disease: future prospects
... Huntington’s Disease Network, who liaise directly with industry partners to ensure the quality and relevance to HD of all new trial proto- ...2,128 patients with HD were prescribed symptom- atic treatments, ... See full document
12
Varenicline improves motor and cognitive symptoms in early Huntington’s disease
... cognitive function in patients with early clinical Huntington’s disease (HD) who were current ...gene-positive patients transition- ing to symptomatic HD were evaluated using the Unified ... See full document
6
Health effects of the Federal Bureau of Prisons tobacco ban
... While the costs, constraints, and challenges of long- term observational studies and interventional trials are a serious impediment to understanding the progression of chronic diseases, a natural experiment is currently ... See full document
5
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
... Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with no clear etiology and a paucity of therapeutic ...lung function, decrease the frequency of acute ... See full document
8
Cancer risk in patients with chronic obstructive pulmonary disease
... all patients from the COPD and the COPD-free comparison group with a recorded history of cancer (exclud- ing non-melanoma skin cancer), HIV, drug abuse, or alcohol- ism prior to the COPD diagnosis (or the ... See full document
9
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with active Crohn’s disease
... bowel disease (IBD) is higher than that in the general population, and IBD is now recognized as one of the risk factors for chronic thromboembolic pul- monary hypertension (CTEPH) [1, ...Furthermore, ... See full document
5
Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
... The established animal models of HD provide us with impor- tant tools to identify therapies for HD. However, these animal models express different forms of mutant Htt and show dif- ferent neurological phenotypes in ... See full document
10
Phosphodiesterase 10A IgGA novel biomarker of paraneoplastic neurologic autoimmunity
... 5 patients that yielded a similar distinctive immunoglobulin G (IgG) staining pattern when applied to murine ...more patients (1 serum and 2 CSF specimens) were identified prospectively (total 7 sera and 4 ... See full document
9
Left ventricular function in patients with chronic obstructive pulmonary disease
... control patients, methoxamine produced an increase in stroke volume index (SVI), in stroke work index (SWI), and stroke power index (SPI), whereas left ventricular end-diastolic pressure (LVEDP) increased only ... See full document
12
Related subjects